Audit 321058

FY End
2023-12-31
Total Expended
$22.59M
Findings
0
Programs
26
Organization: New York Genome Center, Inc. (NY)
Year: 2023 Accepted: 2024-09-25
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.U02 Centralized Omics Resource (core) Year 5 – Rna Transcriptome Sequenc $4.47M Yes 0
93.U04 Comprehensive Reference Atlas Construction, Geolocation and Data Integration for Hubmap Hive $1.29M Yes 0
93.U07 Leidos -Mp2prt Gcc: Ffpe Dna High Coverage Wgs/wes Project $1.16M Yes 0
93.U05 Nygc Bican Sequencing Core - Task Area #1 Manual of Operations $1.07M Yes 0
93.866 Aging Research $567,346 Yes 0
93.395 Cancer Treatment Research $418,604 Yes 0
93.394 Cancer Detection and Diagnosis Research $265,655 Yes 0
93.U10 Sennet Service Contract $249,999 Yes 0
93.859 Biomedical Research and Research Training $241,768 Yes 0
93.U09 Coordinating Center for the Program on the Origins of Gastroesophageal Cancers $215,476 Yes 0
12.420 Military Medical Research and Development $168,442 Yes 0
93.310 Trans-Nih Research Support $111,341 Yes 0
93.393 Cancer Cause and Prevention Research $107,663 Yes 0
93.865 Child Health and Human Development Extramural Research $95,735 Yes 0
93.U03 Perturbation-Response Approaches to Determining the Regulatory Networks Underlying Human Complex Traits $93,715 Yes 0
93.396 Cancer Biology Research $84,162 Yes 0
93.398 Cancer Research Manpower $71,248 Yes 0
93.U08 A Multi-Scale Atlas of Senescence in Diverse Tissue Types $63,238 Yes 0
93.U01 Nci Methylation $50,743 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $47,151 Yes 0
93.242 Mental Health Research Grants $24,869 Yes 0
93.860 Emerging Infections Sentinel Networks $22,124 Yes 0
93.296 A Crispr/cas13 Approach for Identifying Individual Transcript Isoform Function in Cancer $19,180 Yes 0
93.172 Human Genome Research $2,047 Yes 0
93.U06 Nhlbi Trans-Omics for Precision Medicine (topmed) for the Centralized Omics Resource (core 2.0) $1,000 Yes 0
93.855 Allergy and Infectious Diseases Research $723 Yes 0

Contacts

Name Title Type
WKPTJDWG2C68 Maria Joanta Auditee
9178157296 Ernest Obubah Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Center uses the indirect cost rate agreed upon with the federal grantor The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of the New York Genome Center, Inc. (the Center) under programs of the federal government for the year ended December 31, 2023. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Award (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Center, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Center.
Title: Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Center uses the indirect cost rate agreed upon with the federal grantor Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years.
Title: Indirect Cost Rate Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule, if any, represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: The Center uses the indirect cost rate agreed upon with the federal grantor The Center uses the indirect cost rate agreed upon with the federal grantor.